Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response

MeSH terms

• Antibodies, Monoclonal, Humanized / adverse effects
• Churg-Strauss Syndrome* / diagnosis
• Churg-Strauss Syndrome* / drug therapy
• Granulomatosis with Polyangiitis* / diagnosis
• Granulomatosis with Polyangiitis* / drug therapy
• Humans
• Myocarditis* / chemically induced
• Myocarditis* / drug therapy